uniQure
$32.959876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$32.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.80 (-5.18%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell uniQure and other stocks, options, and ETFs commission-free!
About QURE
uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands. The listed name for QURE is uniQure N.V. Ordinary Shares.
CEO
Matthew C. Kapusta
Employees
248
Headquarters
Amsterdam, Noord-Holland
Founded
1998
Market Cap
1.50B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
576.79K
High Today
$35.50
Low Today
$32.75
Open Price
$34.93
Volume
678.13K
52 Week High
$71.45
52 Week Low
$32.75
QURE News
Analyst Ratings
88%
of 17 ratings
Buy
88%
Hold
12%
Sell
0%
QURE Earnings
-$1.21
-$0.81
-$0.40
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
-$0.01 per share